(-)-Deprenyl attenuates spinal motor neuron degeneration and associated locomotor deficits in rats subjected to spinal cord ischemia

Experimental Neurology

Volumn 149, Issue 1, 1998, Pages 123-129

  Ravikumar, R ^a   Lakshmana, M K ^a   Shankaranarayana Rao, B S ^a   Meti, B L ^a   Bindu, P N ^a   Raju, T R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

( ) deprenyl; Locomotor deficit; Motor neurons; Neurodegeneration; Neuroprotection; Spinal cord ischemia; Staircase maze

Indexed keywords

SELEGILINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MOTOR DYSFUNCTION; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD ISCHEMIA;

EID: 0031913673     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6682     Document Type: Article

References (54)

1. Ansari K. S., Yu P. H., Kruck T. P. A., Tatton W. G. Rescue of axotomized immature rat facial motoneurons by R(-) deprenyl: Stereospecificity and independence from monoamine oxidase inhibition. J. Neurosci. 13:1993;1043-1052.
2. Asano T., Takakura K., Suno K., Kikuchi H., Nageri H., Saito I., Tamura A., Ochiai C., Sasaki T. Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double blind trial. J. Neurosurg. 84:1996;792-802.
3. Barkar F. G., Ogilvy C. S. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A meta analysis. J. Neurosurg. 84:1996;405-414.
4. Barone F. C., Lysko P. G., Price W. J., Fenerstein G., Al-Baracanji K. A., Behham C. D., Harries M. H., Baileu S. J., Hunter A. J. SB 201823-A antogonizes calcium currents in central neurons and reduces the effect of focal ischemia in rats and mice. Stroke. 26:1995;1683-1689.
5. Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 3:1991;213-245.
6. Benveniste H., Jorgensen M. B., Sandberg M., Christensen J., Hagberg H., Diemer N. H. Ischemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3. J. Cereb. Blood Flow Metab. 9:1989;629-639.
7. Brown R. D., Whisnant J. P., Sicks J. D., O'Fallon W. H., Wiebers D. O. Stroke incidence, prevalence and survival: Secular trends in Rochester, Minnesota, through 1989. Stroke. 27:1996;373-380.
8. Buchan A. M., Lesiuk H., Barnes K. A., Li H., Huang Z-G., Smith K. E., Xue D. AMPA antagonists: Do they hold more promise for clinical stroke trials than NMDA antagonists. Stroke. 24:1993;1148-1152.
9. Cazal M. L., Pietri S., Culcasi M., Bockaert J. NMDA dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
10. Cameron T., Prodo R., Watson B. D., Carvajal M. G., Holts V. R. Photochemically induced cystic lesion in the rat spinal cord. I. Behavioural and morphological analysis. Exp. Neurol. 109:1990;214-223.
11. Carrillo M. C., Kitani K., Kanai S., Sato Y., Miyasata K., Ivy G. O. (-) Deprenyl increases activities of superoxidase and catalase in certain brain regions in old male mice. Life Sci. 54:1994;975-981.
12. Carter R. L., Ritz L. A., Shank C. P., Scolt E. W., Sypert G. W. Correlative electrophysiological and behavioral evaluation following L5 lesion in the cat: A model of spasticity. Exp. Neurol. 114:1991;206-215.
13. Chan P. H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
14. Chan P. H., Kinouchi H., Epstein C. J., Carlson E., Chan S. F., Imaizumi S., Yang G. Y. Role of superoxide dismutase in ischemic brain injury: Reduction of edema and infarction in transgenic mice following focal cerebral ischemia. Prog. Brain Res. 96:1993;97-104.
15. Chieuh C. C., Huang S. J., Murphy D. L. Suppression of hydroxyl radical formation by MAO inhibition: A novel possible neuroprotective mechanism in dopaminergic neurotoxicity. J. Neural Transm. 41:1994;189-196.
16. Choi D. W. Calcium mediated neurotoxin relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11:1988;465-469.
17. Davis S., Helfaer M. A., Traystman R. J., Hurn P. D. Parallel antioxidant and antiexcitoxicity therapy improves outcome after incomplete global cerebral ischemia in dogs. Stroke. 28:1997;198-205.
18. Ekblom J., Jossan S. S., Ebendal T., Soderstrom S., Oreland L., Aquilonius S-M. Expression of mRNA for neurotrophins and members of the trk family in the rat brain after treatment withL. Acta Neurol. Scand. 84:1993;79-86.
19. Fisher M. Potentially effective therapies for acute ischemic stroke. Eur. J. Neurol. 35:1995;3-7.
20. Fisher M., Jonas S., Sacco R. L. Prophylactic neuroprotection for cerebral ischemic stroke. Eur. J. Neurol. 25:1995;1075-1080.
21. Graham S. H., Chen J., Sharp F. R., Simon R. P. Limiting ischemic injury by inhibition of excitatory amino acid release. J. Cereb. Blood Flow Metab. 13:1993;88-97.
22. Grotta J. The current status of neuronal protective therapy: Why have all neuronal protective drugs worked in animals but none so far in stroke patients. Cerebrovasc. Dis. 4:1994;115-120.
23. Guth L., Zhang Z., Diprospero N. A., Joubin K., Fitch M. T. Spinal cord injury in the rat: Treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function. Exp. Neurol. 126:1994;76-87.
24. Holtz A., Gerdin B. MK-801, an OBSND. Acta Neurol. Scand. 84:1991;334-338.
25. Ishimaru H., Takahashi A., Ikarashi Y., Maruyama Y. Pentabarbital protects against CA1, pyramidal cell death but not dysfunction of hippocampal cholinergic neurons following transient ischemia. Brain Res. 673:1995;112-118.
26. Iwasaki Y., Ikada K., Shiojima T., Kobayashi T., Tayaya N., Kinoshita M. (-) Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons. J. Neurol. Sci. 125:1994;11-13.
27. Ju W. Y. H., Holland D. P., Tatton W. G. (-) Deprenyl alter the time course of death of axotomized facial motoneurons and the hypertrophy of neighboring astrocytes in immature rats. Exp. Neurol. 126:1994;233-246.
28. Kunkel-Bagden E. K., Dai H. N., Bregman B. S. Recovery of function after spinal cord hemisection in new born and adult rats: Differential effects on reflex and locomotor function. Exp. Neurol. 116:1992;40-51.
29. Knollema S., Aukoma W., Hom H., Kovt J., Terhorst G. J. L. Stroke. 26:1995;1883-1887.
30. Lakshmana M. K., Jagadeesh S., Subhash M. N. Increased acetylcholinesterase activity in selected regions of rat CNS after chronic (-) deprenyl administration. Neurochem. Res. 21:1996;1209-1212.
31. Lazarewicz J. W. Calcium transients in brain ischemia: Role in neuronal injury. Acta Neurobiol. Exp. 56:1996;299-312.
32. Liu R. Yang, Yan X., McAdoo D. J. Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: Electrophysiological, histological and neurochemical results. J. Neurochem. 62:1994;37-44.
33. Molander C., Xu Q., Grant G. The cytoarchitectonic organization of the spinal cord in the rat. 1. The lower thoracic and lumbosacral cord. J. Comp. Neurol. 230:1984;133-141.
34. Morimoto T., Mordecai Y-T., Busto R., Martinez E., Ginsberg M. D. Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16:1996;92-99.
35. Munirathinam S., Lakshmana M. K., Raju T. R. (-) Deprenyl attenuates aluminium induced neurotoxicity in primary cortical cultures. Neurodegeneration. 5:1996;161-167.
36. Oh S. M., Betz A. L. Interaction between free radicals and excitatory amino acids in formation of ischemic brain edema in rats. Stroke. 22:1991;915-921.
37. Oldfield E. H., Plunkett R. J., Nylander W. A., Meacham W. F. Barbiturates protection in acute experimental spinal cord ischemia. J. Neurosurg. 56:1982;511-516.
38. Oppenheim R. W. The absence of significant postnatal motor neuron death in the bronchial and lumbar spinal cord of the rat. J. Comp. Neurol. 246:1986;281-286.
39. Pahlmark K., Siesjo B. K. Effects of the spin trapLNtert. Acta Physiol. Scand. 157:1996;41-52.
40. Pappas T. N., Mironovich R. O. Barbiturates induced coma to protect against cerebral ischemia and increased intracranial pressure. Am. J. Hosp. Pharm. 38:1981;494-498.
41. Paschen W. Glutamate excitotoxicity in transient global cerebral ischemia. Acta Neurobiol. Exp. 56:1996;313-322.
42. Seniuk N. A., Henderson J. T., Tatton W. G., Roder J. C. Increased CNTF gene expression in process bearing astrocytes following injury is augmented by R(-) deprenyl. J. Neurosci. Res. 37:1994;278-286.
43. Siesjo B. K. Pathophysiology and treatment of focal cerebral ischemia. I. Pathophysiology. J. Neurosurg. 77:1992;169-184.
44. Snedecor G. W., Cochran W. G. Statistical Methods. 1967;Oxford and IBH, New Delhi.
45. Sprague J. B., Nichols D. E. Inhibition of MAO-B protects against MDMA induced neurotoxicity in the striatum. Psychopharmacology. 118:1995;357-359.
46. Sun J. S., Hang Y. S., Huang I. H., Lu F. J. A simple chemiluminescence assay for detecting oxidative stress in ischemic limb injury. Free Rad. Biol. Med. 20:1996;107-112.
47. Tatton W. G., Ju W. Y. L., Holland D. P., Tai C., Kwan M. (-) Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J. Neurochem. 63:1994;1572-1575.
48. Uyama O., Matsuyama T., Michishita H., Nakamura H., Sugita M. Protective effect of recombinant SOD on transient ischemic injury of CA1 neurons in gerbil. Stroke. 23:1992;75-81.
49. Vizuete M. L., Steffen V., Ayala A., Cono J., Machodo A. Protective effect of (-) deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum. Neurosci. Lett. 152:1993;113-116.
50. Winer B. S. Statitical Principles in Experimental Design. 1971;McGraw-Hill, New York.
51. +. J. Neural Transm. 100:1995;53-61.
52. Zar, J. H. 1984, Biostatistical Analysis, Prentice-Hall International, Englewood Cliffs, NJ.
53. Zhang X., Zuo D-M., Yu P. H. Neuroprotection by R(-) deprenyl andNZN. Neurosci. Lett. 186:1995;45-48.
54. Zivin J. A., Degirolani U., Hurwitz E. L. Spectrum of neurological deficits in experimental CNS ischemia. Arch. Neurol. 39:1982;408-412.